RE: Time to buy in here, if you ask me.29 Aug 2024 18:28
Fevertreeman.
Only the top management know about how the revenue is going from the sales of the Parsortix machine, the associated consumables etc.... Plus of course the assays they now offer. There is a lot more to Angle than just the prospect of huge profits from Pharma Co's measuring the effect of their new cancer drugs on the circulating tumour cells, so they have a "running update" on the drugs effect. I am absolutely astounded that more Companies doing cancer drug trials have not (yet) paid Angle to help them get this information. The word "flabbergasted" springs to mind. These massive Plc's pay millions to do cancer drug trials, and they won't even pay Angle to monitor the effect of the drug on the circulating tumour cells (CTC’s, cancerous cells) that Angle's Parsortix machine can now catch for testing. It is truly astounding to me. Maybe we will get an avalanche of Pharma Plc’s running to Angle to get on board……………. Angle only have so much capacity to produce the assays to test whatever the Pharma Co’s want to in the CTC’s. Just half a dozen or so more contracts to produce assays to test “x” in the CTC’s would find them struggling IMHO. That would be about £3 million, on top of their revenue from all the other things they do. That would be to produce the assays only. Mr Newland has already said actually using the assays and doing the analysis costs about $2,500 per tube of blood. So the actual testing for each patient before, during and after the trial would be many millions more.
All IMHO.